Analytical techniques reveal ESI-MS spectrum and HPLC analysis of DOTA-ALB-03, highlighting fibroblast targeting.
Figure S4. ESI-MS spectrum and HPLC analysis of DOTA-ALB-03. See main text for corresponding analytical conditions.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: